Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frank Buck who wrote (93)	1/8/1998 11:41:00 PM
From: Sigmund	Read Replies (2) of 178

"denigerate" no such word. Did I say "denigrate"? perhaps but I don't recall. I recall saying that IR people shouldn't be making negative comments about the products of other companies in their sector. It can be easily misconstrued as being non-objective. Product comparisons are the province of the marketing department and carry far more weight when provided by third parties.......Didn't you know that I was a consultant.....we are the only ones really allowed to do this type of thing<g>. Securities analysts do it too but they shouldn't unless they first retain a competant consultant<g>. But don't worry about Dana. She is ok and she knows that I think that she is ok. Why I am posting this on this site? I don't know.....our private chat room. Hi Jim! As far as I know George Sorros continues to hold NeoPath. I have no idea exactly why the stock is going up but I don't think I would want to be short this stock at $15 on Jan 28. Being long at $30 at 4 pm on January 28 doesn't sound like a real comfortable position to be in either so I think that there may be a pretty wide trading range here as those who are optimistic and those who are risk adverse fight it out.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next